ES513565A0 - Procedimiento de preparacion de un nuevo derivado de benzoilfenil-piperidina. - Google Patents

Procedimiento de preparacion de un nuevo derivado de benzoilfenil-piperidina.

Info

Publication number
ES513565A0
ES513565A0 ES513565A ES513565A ES513565A0 ES 513565 A0 ES513565 A0 ES 513565A0 ES 513565 A ES513565 A ES 513565A ES 513565 A ES513565 A ES 513565A ES 513565 A0 ES513565 A0 ES 513565A0
Authority
ES
Spain
Prior art keywords
benzoylphenyl
procedure
preparation
new
piperidine derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES513565A
Other languages
English (en)
Other versions
ES8304936A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SORI SOC RECH IND
Original Assignee
SORI SOC RECH IND
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SORI SOC RECH IND filed Critical SORI SOC RECH IND
Publication of ES8304936A1 publication Critical patent/ES8304936A1/es
Publication of ES513565A0 publication Critical patent/ES513565A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ES513565A 1981-06-29 1982-06-28 Procedimiento de preparacion de un nuevo derivado de benzoilfenil-piperidina. Granted ES513565A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8112745A FR2508445A1 (fr) 1981-06-29 1981-06-29 Nouveaux derives de benzoyl-phenyl-piperidine, leur procede de preparation et leur application, notamment en therapeutique

Publications (2)

Publication Number Publication Date
ES8304936A1 ES8304936A1 (es) 1983-03-16
ES513565A0 true ES513565A0 (es) 1983-03-16

Family

ID=9259970

Family Applications (1)

Application Number Title Priority Date Filing Date
ES513565A Granted ES513565A0 (es) 1981-06-29 1982-06-28 Procedimiento de preparacion de un nuevo derivado de benzoilfenil-piperidina.

Country Status (26)

Country Link
US (2) US4528294A (es)
EP (1) EP0069012B1 (es)
JP (1) JPS588061A (es)
KR (1) KR880001298B1 (es)
AR (1) AR230048A1 (es)
AT (1) ATE9795T1 (es)
AU (1) AU550320B2 (es)
CA (1) CA1187501A (es)
CS (1) CS235542B2 (es)
DD (1) DD202557A5 (es)
DE (1) DE3260949D1 (es)
DK (1) DK152668C (es)
ES (1) ES513565A0 (es)
FI (1) FI77447C (es)
FR (1) FR2508445A1 (es)
GR (1) GR76401B (es)
HU (1) HU189150B (es)
IE (1) IE53189B1 (es)
IL (2) IL66123A (es)
NO (1) NO160136C (es)
OA (1) OA07133A (es)
PH (1) PH17368A (es)
PT (1) PT75135B (es)
SU (1) SU1147251A3 (es)
YU (1) YU43799B (es)
ZA (1) ZA824536B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL82573A0 (en) * 1986-05-30 1987-11-30 Sori Soc Rech Ind Preparation of benzoylphenyl-piperidine derivatives
FR2620027A1 (fr) * 1987-09-09 1989-03-10 Fournier Innovation Synergie Nouvelle utilisation de la (5-amino-2-(4-methyl-1-piperidinyl)phenyl)-(4-chlorophenyl)-methanone
AU4971600A (en) 1999-05-21 2000-12-12 Eli Lilly And Company Immunopotentiator agents
JP2003528830A (ja) * 2000-03-10 2003-09-30 ファルマシア・コーポレーション テトラヒドロベンゾチエピン類の製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202655A (en) * 1962-04-27 1965-08-24 Yvon G Perron 6-[alpha-substituted-alpha-(2-or 3-heterocyclic) acetamido] penicillanic acid and nontoxic salts thereof
NL124621C (es) * 1962-11-13
FR1375300A (fr) * 1962-11-13 1964-10-16 Hoffmann La Roche Dérivés de benzophénone et leur préparation
FR1403939A (fr) * 1963-06-07 1965-06-25 Hoffmann La Roche Procédé pour la préparation de dérivés de benzodiazépine
US3668199A (en) * 1966-06-13 1972-06-06 Upjohn Co 1,3-aminoalcohols
FR1526708A (fr) * 1966-06-13 1968-05-24 Upjohn Co 1.3-amino-alcools, leurs intermédiaires et dérivés et leur procédé de préparation
FR1530393A (fr) * 1966-07-11 1968-06-21 Hoffmann La Roche Procédé pour la préparation de dérivés de pipéridine
IE34545B1 (en) * 1969-10-01 1975-06-11 Continental Pharma Amino-alcohols,their salts and process for preparing the same
HU167949B (es) * 1973-07-26 1976-01-28
US4064121A (en) * 1973-07-26 1977-12-20 Richter Gedeon Vegyeszeti Gyar Rt. Substituted nitrobenzophenone derivatives and a process for the preparation thereof
HU167950B (es) * 1973-07-26 1976-01-28
US4021563A (en) * 1975-02-06 1977-05-03 Sven Eric Harry Hernestam Method of treating cardiac arrhythmia with γ-piperidino-butyrophenones
IE49998B1 (en) * 1979-08-06 1986-01-22 Merrell Dow Pharma 4-(naphthalenyloxy)piperidine derivatives

Also Published As

Publication number Publication date
NO822185L (no) 1982-12-30
CA1187501A (en) 1985-05-21
SU1147251A3 (ru) 1985-03-23
IL66123A (en) 1986-02-28
JPH0127062B2 (es) 1989-05-26
PH17368A (en) 1984-08-06
IE821475L (en) 1982-12-29
US4528294A (en) 1985-07-09
FI822215L (fi) 1982-12-30
PT75135A (fr) 1982-07-01
AR230048A1 (es) 1984-02-29
FI77447B (fi) 1988-11-30
IE53189B1 (en) 1988-08-17
YU141582A (en) 1985-03-20
AU550320B2 (en) 1986-03-20
ATE9795T1 (de) 1984-10-15
GR76401B (es) 1984-08-10
JPS588061A (ja) 1983-01-18
DK152668B (da) 1988-04-11
FR2508445B1 (es) 1984-02-10
AU8542982A (en) 1983-01-06
ES8304936A1 (es) 1983-03-16
KR880001298B1 (ko) 1988-07-22
EP0069012B1 (fr) 1984-10-10
PT75135B (fr) 1984-05-25
DK152668C (da) 1988-09-19
ZA824536B (en) 1983-04-27
FR2508445A1 (fr) 1982-12-31
DD202557A5 (de) 1983-09-21
IL76287A0 (en) 1986-01-31
YU43799B (en) 1989-12-31
CS235542B2 (en) 1985-05-15
NO160136C (no) 1989-03-15
NO160136B (no) 1988-12-05
HU189150B (en) 1986-06-30
IL66123A0 (en) 1982-09-30
DE3260949D1 (en) 1984-11-15
US4680402A (en) 1987-07-14
DK289382A (da) 1982-12-30
EP0069012A1 (fr) 1983-01-05
OA07133A (fr) 1984-03-31
KR840000514A (ko) 1984-02-22
FI77447C (fi) 1989-03-10
FI822215A0 (fi) 1982-06-21

Similar Documents

Publication Publication Date Title
ES517542A0 (es) Un procedimiento para la preparacion de derivados de 3-hidroxi-ml-236-b.
ES517732A0 (es) Un procedimiento para la preparacion de derivados de prolina.
ES517222A0 (es) Un procedimiento para la preparacion de derivados de acilmorrfinano.
ES514264A0 (es) Un procedimiento para la preparacion de derivados de tiazolidi-nilalquilen-piperazinas.
ES512880A0 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
ES509437A0 (es) Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos.
ES513880A0 (es) Un procedimiento para la preparacion de derivados de triazolurea.
ES521471A0 (es) Un procedimiento para la preparacion de un derivado de carbostirilo.
ES515655A0 (es) Un procedimiento para la preparacion de derivados de benzotiazolina.
ES510611A0 (es) Un procedimiento para la preparacion de derivados de desoxiuridina.
ES513967A0 (es) Un procedimiento para la preparacion de derivados de etanola-mina.
ES518291A0 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
ES522459A0 (es) Un procedimiento para la preparacion de un derivado de ascoclorina.
ES507939A0 (es) Un procedimiento de preparacion de nuevos derivados de la hidroxifenil-tetrahidropiridina .
ES514263A0 (es) Un procedimiento para la preparacion de derivados de espiroti-azolidinil-piperazina.
ES513565A0 (es) Procedimiento de preparacion de un nuevo derivado de benzoilfenil-piperidina.
ES508775A0 (es) Un procedimiento para la preparacion de derivados de ciclo- hepteno.
ES513332A0 (es) "procedimiento para la preparacion de un nuevo derivado de vincamina".
ES517852A0 (es) Un procedimiento para la preparacion de derivados de bencenosulfonamidas.
ES510155A0 (es) "procedimiento para la preparacion de un nuevo derivado de alquilenodiamina".
ES515365A0 (es) Un procedimiento para la preparacion de un derivado de furanocremona.
ES512463A0 (es) Un procedimiento para la preparacion de un derivado de beta-lactama.
ES521597A0 (es) Procedimiento de preparacion de compuestos piridotienopiridacinicos.
ES514864A0 (es) Un procedimiento para la preparacion de derivados de trifluormetanosulfonanilida.
ES514486A0 (es) Un procedimiento para la preparacion de derivados de aminonaftaceno.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603